Research work · 2017
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark M. Yarchoan, Alexander C. Hopkins, Elizabeth M. Jaffee
New England Journal of Medicine
Abstract
In a survey of the spectrum of mutational burdens in 27 types of cancers, there was a correlation between an increased mutational burden and the response to checkpoint inhibition of PD-1 and PD-L1.
DOI: 10.1056/nejmc1713444